CliffBio
small molecule

OCTREOSCAN

INDIUM IN-111 PENTETREOTIDE KIT

Loss of exclusivity—loss of exclusivity
CompanyCurium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameOCTREOSCAN
Active ingredientINDIUM IN-111 PENTETREOTIDE KIT
Strength3mCi/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJune 1994
Marketing statusRX

More from Curium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.